NCT04432753

Brief Summary

This online randomized controlled trial seeks to determine if inclusion of incidental findings information in a lung cancer screening decision aid affects screening intent among screening-eligible individuals. Participants will view either a decision aid with incidental findings information or without and indicate their intent to pursue lung cancer screening. Hypothesis: Inclusion of incidental findings in a decision aid will decrease intent to screen among participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
419

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 16, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

July 16, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2020

Completed
Last Updated

December 10, 2020

Status Verified

December 1, 2020

Enrollment Period

1 month

First QC Date

May 28, 2020

Last Update Submit

December 8, 2020

Conditions

Keywords

Incidental Findings

Outcome Measures

Primary Outcomes (1)

  • Percentage of individuals who plan to pursue lung cancer screening

    This will be assessed by a survey item where participants indicate their response to a statement of whether they plan to pursue lung cancer screening, with answer choices being strongly agree, agree, disagree and strongly disagree. Comparison between the intervention and control groups will be made.

    Day 1

Secondary Outcomes (6)

  • Mean score on scale of lung cancer screening knowledge

    Day 1

  • Mean rating of benefit and harms of screening

    Day 1

  • Percentage of Time Lung Cancer Screening Benefit and Harms are ranked first and last

    Day 1

  • Mean ranking of benefit and harms of screening

    Day 1

  • Percentage of time each lung cancer screening harm is ranked highest of the five potential harms

    Day 1

  • +1 more secondary outcomes

Study Arms (2)

Decision aid with incidental findings information

EXPERIMENTAL

Participants in this arm will view a video decision aid that include information on incidental findings in lung cancer screening.

Behavioral: Lung Cancer Screening Decision Aid with Incidental Findings Information

Decision aid without incidental findings information

ACTIVE COMPARATOR

Participants in this arm will view a video decision aid that does not include information on incidental findings in lung cancer screening.

Behavioral: Lung Cancer Screening Decision Aid without Incidental Findings Information

Interventions

The intervention consists of a previously tested and developed brief lung cancer screening video decision aid with the addition of information on incidental findings for lung cancer screening.

Decision aid with incidental findings information

The intervention consists of a previously tested and developed brief lung cancer screening video decision aid that does not include information on incidental findings.

Decision aid without incidental findings information

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • year old male or female
  • Current or former smoker who quit within the last 15 years
  • At least 30 pack years of smoking

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27514, United States

Location

Related Publications (1)

  • Clark SD, Reuland DS, Brenner AT, Jonas DE. Effect of Incidental Findings Information on Lung Cancer Screening Intent: a Randomized Controlled Trial. J Gen Intern Med. 2022 Nov;37(14):3676-3683. doi: 10.1007/s11606-022-07409-4. Epub 2022 Feb 2.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Stephen Clark, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Daniel Jonas, MD, MPH

    University of North Carolina, Chapel Hill

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 16, 2020

Study Start

July 16, 2020

Primary Completion

August 22, 2020

Study Completion

August 22, 2020

Last Updated

December 10, 2020

Record last verified: 2020-12

Locations